Drug use profile in outpatient children and adolescents in different Italian regions

BMC Pediatrics

on behalf of the Interregional Italian Drug Utilisation Group¹  Maurizio Bonati¹  Antonio Clavenna¹  Daniele Piovani¹ 

[1] Department of Public Health, Laboratory for Mother and Child Health, IRCCS - Istituto di Ricerche Farmacologiche “Mario Negri”, Via Giuseppe La Masa 19, Milan, 20156, Italy

关键词: Outpatient;    Prescription;    Drug utilisation;    Adolescent;    Children;   

Others  :  1145114
DOI  :  10.1186/1471-2431-13-46

 received in 2012-09-19, accepted in 2013-03-27,  发布年份 2013

【 摘 要 】

Background

Large differences exist in the prevalence rate of drugs prescribed to children and adolescents between and within countries. The aim of this study was to evaluate child and adolescent drug prescription patterns in Italy in an extra-hospital setting at the regional and Local Health Unit (LHU) levels.

Methods

Data sources were three regional prescription databases. Data concerning the year 2008 were evaluated. A total of 3.3 million children and adolescents were included. Drug prevalence and prescription rates were evaluated at the regional and LHU levels. The correlation between mean latitude, average annual income, hospitalisation rate, number of paediatricians per 1,000 resident children, and prevalence rate was evaluated by LHU using a linear multiple regression analysis.

Results

Large differences were found across Italian regions and LHUs. The mean prevalence rate was 56.4% (95% CI 56.3-56.5%; 51.2-65.4% among regions) and, at the LHU level, ranged from 43.1% to 70.0% (higher in the South). A total of 878 drugs were prescribed, 175 of which were shared by all LHUs. Amoxicillin clavulanate was the most used drug in all regions and in 31 of 33 LHUs. Amoxicillin was the drug with the highest variability in use between LHUs (9.1-52.1% of treated children). An inverse correlation was found between prevalence rate and both latitude (p < 0.0001) and average annual income (p = 0.0002).

Conclusions

The use of drugs in children and adolescents is higher in southern Italy and is inversely related to latitude and average annual income. More efforts should be devoted to informing physicians, patients and policy makers in order to plan effective initiatives to improve the situation.

【 授权许可】

   
2013 Piovani et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Clavenna A, Bonati M: Drug prescriptions to outpatient children: a review of the literature. Eur J Clin Pharmacol 2009, 65:749-755.
• [2]Clavenna A, Bonati M: Differences in antibiotic prescribing in paediatric outpatients. Arch Dis Child 2011, 96:590-595.
• [3]Bianchi M, Clavenna A, Bonati M: Inter-country variations in anti-asthmatic drug prescriptions for children. Systematic review of studies published during the 2000–2009 period. Eur J Clin Pharmacol 2010, 66:929-936.
• [4]Sen EF, Verhamme KM, Neubert A, Hsia Y, Murray M, Felisi M: Assessment of pediatric asthma drug use in three European countries; a TEDDY study. Eur J Pediatr 2011, 170:81-92.
• [5]Hsia Y, Neubert A, Sturkenboom MC, Murray ML, Verhamme KM, Sen F: Comparison of antiepileptic drug prescribing in children in three European countries. Epilepsia 2010, 51:789-796.
• [6]Neubert A, Hsia Y, de Jong-van den Berg LT, Janhsen K, Glaeske G, Furu K: Comparison of anti-diabetic drug prescribing in children and adolescents in seven European countries. Br J Clin Pharmacol 2011, 72:969-977.
• [7]Clavenna A, Berti A, Gualandi L, Rossi E, De Rosa M, Bonati M: Drug utilisation profile in the Italian paediatric population. Eur J Pediatr 2009, 168:173-180.
• [8]Clavenna A, Sequi M, Bortolotti A, Merlino L, Fortino I, Bonati M: Determinants of the drug utilization profile in the paediatric population in Italy's Lombardy Region. Br J Clin Pharmacol 2009, 67:565-571.
• [9]World Health Organization: Model List of Essential Medicines for Children. 2011. available at: http://whqlibdoc.who.int/hq/2011/a95054_eng.pdf webcite accessed 5 September 2012
• [10]Corrao G, Zambon A, Parodi A, Mezzanzanica M, Merlino L, Cesana G: Do socioeconomic disparities affect accessing and keeping antihypertensive drug therapy? Evidence from an Italian population-based study. J Hum Hypertens 2009, 23:238-244.
• [11]Masiero G, Filippini M, Ferech M, Goossens H: Socioeconomic determinants of outpatient antibiotic use in Europe. Int J Public Health 2010, 55:469-478.
• [12]Cucinotta G, Mazzaglia G, Toscano MA, Arcoraci V, Tempera G, Salmeri M: Exploring the variability in antibiotic prescribing profiles among paediatricians from two different areas of Italy. Pharmacol Res 2002, 45:369-374.
• [13]Moro ML, Marchi M, Gagliotti C, Di Mario S, Resi D: Why do paediatricians prescribe antibiotics? Results of an Italian regional project. BMC Pediatr 2009, 6:9-69.
• [14]Grosso G, Marventano S, Ferranti R, Mistretta A: Pattern of antibiotic use in the community: νon-adherence and self-prescription rates in an Italian urban population. Mol Med Report 2012, 5:1305-1310.
• [15]Agodi A, Barchitta M, Agodi MC, Scuderi M, Sciacca S: Non compliance to therapeutic prescriptions in paediatric patients: role of social communication. Ann Ig 2004, 16:157-162.
• [16]Bonati M, Pandolfini C: Is it time for a European formulary of paediatric medicines? Arch Dis Child 2004, 89:890-891.
• [17]Piovani D, Clavenna A, Cartabia M, Bonati M: The regional profile of antibiotic prescriptions in Italian outpatient children. Eur J Clin Pharmacol 2012, 68:997-1005.
• [18]Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y: The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005, 26:166-174.
• [19]Salvo F, Polimeni G, Moretti U, Conforti A, Leone R, Leoni O: Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy. J Antimicrob Chemother 2007, 60:121-126.
• [20]American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media: Diagnosis and management of acute otitis media. Pediatrics 2004, 113:1451-1465.
• [21]Centre for Clinical Practice at NICE: Prescribing of antibiotics for self-limiting respiratory tract infections in adults and children in primary care. NICE clinical guideline. http://guidance.nice.org.uk/CG69/Guidance webcite accessed 5 September 2012
• [22]Chiappini E, Principi N, Mansi N, Serra A, De Masi S, Camaioni A: Management of acute pharyngitis in children: summary of the italian national institute of health guidelines. Clin Ther 2012, 34:1442-1458.
• [23]Chiappini E, Regoli M, Bonsignori F, Sollai S, Parretti A, Galli L: Analysis of different recommendations from international guidelines for the management of acute pharyngitis in adults and children. Clin Ther 2011, 33:48-58.
• [24]Faringotonsillite in età pediatrica. Regional guidelines – Regional Healthcare System, Emilia Romagna region. http://assr.regione.emilia-romagna.it/it/servizi/pubblicazioni/dossier/doss153/at_download/file webcite accessed 5 September 2012
• [25]Marchisio P, Bellussi L, Di Mauro G, Doria M, Felisati G, Longhi R: Acute otitis media: From diagnosis to prevention. Summary of the Italian guideline. Int J Pediatr Otorhinolaryngol 2010, 74:1209-1216.
• [26]Otite media acuta in età pediatrica. Regional guidelines - Regional Healthcare System, Emilia Romagna region. http://assr.regione.emilia-romagna.it/it/servizi/pubblicazioni/dossier/doss154/at_download/file webcite accessed 5 September 2012
• [27]Otite Media Acuta: dalla diagnosi alla prevenzione. Guidelines from Società Italiana di Pediatria. available at: http://www.sipps.it/pdf/lineeguida/otite.pdf webcite accessed 14 November 2012
• [28]Gestione della Faringotonsillite in Età Pediatrica: Sintesi e Commento. Italian guidelines from Società Italiana di Pediatria. available at: http://www.sipps.it/pdf/lineeguida/faringotonsillite.pdf webcite accessed 14 November 2012
• [29]Mauri L, Narducci M, Nova A, Zanetto F: Infezioni respiratorie, self help e prescrizione antibiotica nella pratica ambulatoriale. Medico e Bambino 2010, 29:569-574.
• [30]Smith LA, Bokhour B, Hohman KH, Miroshnik I, Kleinman KP, Cohn E: Modifiable risk factors for suboptimal control and controller medication underuse among children with asthma. Pediatrics 2008, 122:760-769.
• [31]Stempel DA, McLaughin TP, Stanford RH, Fuhlbrigge AL: Patterns of asthma control: a 3-year analysis of patient claims. J Allergy Clin Immunol 2005, 115:935-939.
• [32]Cazzato T, Pandolfini C, Campi R, Bonati M: Drug prescribing in out-patient children in Southern Italy. Eur J Clin Pharmacol 2001, 57:611-616.
• [33]L’uso dei farmaci in Italia – rapporto nazionale anno 2008, OsMed. available at: http://www.healthsearch.it/documenti/Archivio/Rapporto_Osmed/Rapporto_Osmed%202008.pdf webcite, accessed 20 March, 2013